[End of a near-monopoly on DNA sequencing].

Séquençage d’ADN, la fin d’un quasi-monopole ? - Chroniques génomiques.

Journal

Medecine sciences : M/S
ISSN: 1958-5381
Titre abrégé: Med Sci (Paris)
Pays: France
ID NLM: 8710980

Informations de publication

Date de publication:
May 2023
Historique:
medline: 25 5 2023
pubmed: 23 5 2023
entrez: 23 5 2023
Statut: ppublish

Résumé

DNA sequencing costs have steadily decreased during the last decade, but the dominant technology (short-read sequencing, Illumina) has seen comparatively little competition after an initial flurry. This phase is now over, with serious competition involving both established and new companies as well as the growing importance of long-read sequencing. The hundred-dollar genome is in sight, and this will have a major impact on many fields of biology.

Identifiants

pubmed: 37219353
doi: 10.1051/medsci/2023061
pii: msc230080
doi:

Types de publication

English Abstract News

Langues

fre

Sous-ensembles de citation

IM

Pagination

469-473

Informations de copyright

© 2023 médecine/sciences – Inserm.

Références

Jordan B. Une révolution longuement attendue. Med Sci (Paris) 2008 ; 24 : 869–873.
Heather JM, Chain B. The sequence of sequencers : The history of sequencing DNA. Genomics 2016 ; 107 : 1–8.
https://ourworldindata.org/grapher/cost-of-sequencing-a-full-human-genome.
https://seekingalpha.com/article/4575505-gene-sequencing-market-illumina-pacific-bio-oxford-nanopore-comparison.
Halldorsson BV, Eggertsson HP, Moore CHS, et al. The sequences of 150,119 genomes in the UK Biobank. Nature 2022 : 607; 732–40.
A bid to sequence all species, in News at a glance, Science 2018; 362 : 504–6.
Rhie A, McCarthy SA, Fedrigo O, et al. Towards complete and error-free genome assemblies of all vertebrate species. Nature 2021; 592 : 737–46.
https://www.genomeweb.com/sequencing/sequencing-instrument-launches-2022-portend-heated-competition#.ZA88OB-ZOFg.
Jarvis ED, Formenti G, Rhie A, et al. Semi-automated assembly of high-quality diploid human reference genomes. Nature. 2022; 611 : 519–31.
Jordan B. Actualités du séquençage d’ADN. Med Sci (Paris) 2019 ; 35 : 81–83.
Jordan B. Séquençage d’ADN : l’offensive des nanopores. Med Sci (Paris) 2017 ; 33 : 801–804.
Montel F. Séquençage de l’ADN par nanopores : résultats et perspectives. Med Sci (Paris) 2018 ; 34 : 161–165.
Quick J, Loman NJ, Duraffour S, et al. Real-time, portable genome sequencing for Ebola surveillance. Nature 2016 ; 530 : 228–232.
Endo I, Soeda E, Murakami Y, Nishi K. Human genome analysis system. Nature 1991 ; 352 : 89–90.

Auteurs

Bertrand Jordan (B)

Biologiste, généticien et immunologiste, Président d'Aprogène (Association pour la promotion de la Génomique), 13007 Marseille, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH